TP53 mutations in tumor cells increased the level of hypoxia-induced factor-1α (HIF-1α) and augmented HIF-1α-dependent transcriptional activation of the VEGF gene in response to hypoxia33. The gene discussed is HIF1A; the disease is neoplasm.